174 related articles for article (PubMed ID: 8164353)
1. [Pharmacological action of 9alpha-fluorohydrocortisone as a mineralocorticoid].
Sekihara H
Nihon Rinsho; 1994 Mar; 52(3):583-6. PubMed ID: 8164353
[TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid and glucocorticoid receptors and their differential effects on memory performance in people with Addison's disease.
Tytherleigh MY; Vedhara K; Lightman SL
Psychoneuroendocrinology; 2004 Jul; 29(6):712-23. PubMed ID: 15110920
[TBL] [Abstract][Full Text] [Related]
3. The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone.
Bamberg K; William-Olsson L; Johansson U; Jansson-Löfmark R; Hartleib-Geschwindner J
J Renin Angiotensin Aldosterone Syst; 2019; 20(1):1470320319827449. PubMed ID: 30813831
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease.
Cohen N; Gilbert R; Wirth A; Casley D; Jerums G
J Clin Endocrinol Metab; 1996 Apr; 81(4):1411-5. PubMed ID: 8636343
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid substitution and monitoring in primary adrenal insufficiency.
Quinkler M; Oelkers W; Remde H; Allolio B
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):17-24. PubMed ID: 25617169
[TBL] [Abstract][Full Text] [Related]
6. [Synthetic mineralocorticoid].
Miyamori I
Nihon Rinsho; 2008 Jan; 66(1):125-9. PubMed ID: 18193551
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of atrial natriuretic peptide (ANP) during mineralocorticoid escape in normal man.
Wambach G; Götz S; Suckau G; Kaufmann W
Klin Wochenschr; 1986; 64 Suppl 6():53-7. PubMed ID: 2948064
[TBL] [Abstract][Full Text] [Related]
8. [A mineralocorticoid effective by oral administration: 9-alpha-fluorohydrocortisone (Astonin H)].
Maximilian VV; Oancea R; Lazăr V
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(5):469-72. PubMed ID: 24883
[No Abstract] [Full Text] [Related]
9. Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor.
Whitworth JA; Kelly JJ
J Endocrinol Invest; 1995; 18(7):586-91. PubMed ID: 9221279
[No Abstract] [Full Text] [Related]
10. The action of fludrocortisone and aldosterone on sodium potassium metabolism in Addison's disease.
MUNRO DS
Clin Sci; 1958; 17(2):205-16. PubMed ID: 13537340
[No Abstract] [Full Text] [Related]
11. Glucocorticoids with or without fludrocortisone in septic shock: a narrative review from a biochemical and molecular perspective.
Nethathe GD; Lipman J; Anderson R; Fuller PJ; Feldman C
Br J Anaesth; 2024 Jan; 132(1):53-65. PubMed ID: 38030548
[TBL] [Abstract][Full Text] [Related]
12. Effect of administered mineralocorticoids or ACTH in pregnant women. Attenuation of kaliuretic influence of mineralocorticoids during pregnancy.
Ehrlich EN; Lindheimer MD
J Clin Invest; 1972 Jun; 51(6):1301-9. PubMed ID: 4336938
[TBL] [Abstract][Full Text] [Related]
13. Exogenous mineralocorticoid hormone improves predialysis hyperkalemia in anephric man.
Whalen JE; Cohen LH
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():1-4. PubMed ID: 756027
[No Abstract] [Full Text] [Related]
14. Severe symptomatic hyperkalemia in an adrenalectomized woman due to enhanced mineralocorticoid requirement.
Daughaday WH; Rendleman D
Ann Intern Med; 1967 Jun; 66(6):1197-203. PubMed ID: 6027948
[No Abstract] [Full Text] [Related]
15. Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1.
Schweiger B; Moriarty MW; Cadnapaphornchai MA
Curr Opin Pediatr; 2009 Apr; 21(2):269-71. PubMed ID: 19657313
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression.
Heering PJ; Kurschat C; Vo DT; Klein-Vehne N; Fehsel K; Ivens K
Clin Transplant; 2004 Apr; 18(2):186-92. PubMed ID: 15016134
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid resistance.
Zennaro MC
Steroids; 1996 Apr; 61(4):189-92. PubMed ID: 8732998
[TBL] [Abstract][Full Text] [Related]
18. Mineralocorticoid replacement in Addison's disease.
Thompson DG; Mason AS; Goodwin FJ
Clin Endocrinol (Oxf); 1979 May; 10(5):499-506. PubMed ID: 476980
[TBL] [Abstract][Full Text] [Related]
19. Relationships among urinary kallikrein, mineralocorticoids and human hypertensive disease.
Margolius HS; Horwitz D; Pisano JJ; Keiser HR
Fed Proc; 1976 Feb; 35(2):203-6. PubMed ID: 1248655
[TBL] [Abstract][Full Text] [Related]
20. High plasma levels of endothelin-1 in untreated Addison's disease.
Letizia C; Centanni M; Scuro L; Canettieri G; Cerci S; De Ciocchis A; D'Ambrosio C; Scavo D
Eur J Endocrinol; 1996 Dec; 135(6):696-9. PubMed ID: 9025715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
